Application of arsenazo III in the preparation and characterization of an albumin-linked, gadolinium-based macromolecular magnetic resonance contrast agent

Journal of Neuroscience Methods

Volumn 157, Issue 2, 2006, Pages 238-245

  Nagaraja, Tavarekere N ^a   Croxen, Richard L ^a   Panda, Swayamprava ^b   Knight, Robert A ^b   Keenan, Kelly A ^a   Brown, Stephen L ^a   Fenstermacher, Joseph D ^a   Ewing, James R ^b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Brain tumor; Gadomer 17; Gd DTPA; MRI

Indexed keywords

ARSENAZO 3; BOVINE SERUM ALBUMIN; CHELATING AGENT; CONTRAST MEDIUM; DEXAMETHASONE; EVANS BLUE; GADOLINIUM; GADOMER 17; PENTETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLORIMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIALYSIS; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; FREEZE DRYING; GLIOSARCOMA; MACROMOLECULE; MALE; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

ANIMALS; ARSENAZO III; BRAIN NEOPLASMS; CONTRAST MEDIA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT ANTIBODY TECHNIQUE; GADOLINIUM; GLIOSARCOMA; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, INBRED F344; SERUM ALBUMIN, BOVINE;

EID: 33748304192     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2006.05.013     Document Type: Article

References (38)

1. Adam G., Muhler A., Spuntrup E., Neuerburg J.M., Kilbinger M., Bauer H., et al. Differentiation of spontaneous canine breast tumors using dynamic magnetic resonance imaging with 24-gadolinium-DTPA-cascade-polymer, a new blood-pool agent. Invest Radiol 31 (1996) 267-274
2. Adzamli K., Yablonskiy D.A., Chicoine M.R., Won E.K., Galen K.P., Zahner M.C., et al. Albumin-binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model. Magn Reson Med 49 (2003) 586-590
3. Brady E.D., Chong H.-S., Milenic D.E., and Brechbiel M.W. Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copper. Nucl Med Biol 31 (2004) 795-802
4. Brix G., Schad L.R., Deimling M., and Lorenz W.J. Fast and precise T1 imaging using a TOMROP sequence. Magn Reson Imaging 8 (1990) 351-356
5. Cassidy R.M., Elchuck S., Elliot N.L., Green L.W., Knight C.H., and Recoskie B.M. Dynamic ion exchange chromatography for the determination of number of fissions in uranium dioxide fuels. Anal Chem 58 (1986) 1181-1186
6. Ewing J.R., Wei L., Knight R.A., Pawa S., Nagaraja T.N., Brusca T., et al. Direct comparison of local cerebral blood flow rates measured by MRI arterial spin-tagging and quantitative autoradiography in a rat model of experimental cerebral ischemia. J Cereb Blood Flow Metab 23 (2003) 198-209
7. 14C-sucrose in areas of blood-brain opening. Magn Reson Med 50 (2003) 283-292
8. Ewing J.R., Brown S.L., Lu M., Panda S., Ding G., Knight R.A., et al. Model selection in MRI measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor. J Cereb Blood Flow Metab 26 (2006) 310-320
9. Fritz J.S., Oliver R.T., and Pietrzyk D.J. Chelometric titrations using an azoarsonic acid indicator. Anal Chem 30 (1958) 1111-1114
10. Gouin S., and Winnik F.M. Quantitative assays of the amount of diethylenetriaminepentaacetic acid conjugated to water-soluble polymers using isothermal titration calorimetry and colorimetry. Bioconjug Chem 12 (2001) 372-377
11. Greg Pippin C., Parker T.A., McMurry T.J., and Brechbiel M.W. Spectroscopic method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugate. Bioconjug Chem 3 (1992) 342-345
12. Hawkins C.P., Munro P.M.G., Mackenzie F., Kesselring J., Tofts P.S., du Boulay E.P.G., et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studies by gadolinium-DTPA and protein markers. Brain 113 (1990) 365-378
13. Hnatowich D.J., Layne W.W., and Childs R.L. The preparation and labeling of DTPA-coupled albumin. Int J Appl Radiat Isot 33 (1982) 327-332
14. Hvattum E., Normann P.T., Jamieson G.C., Lai J.-J., and Skotland T. Detection and quantitation of gadolinium chelates in human serum and urine by high-performance liquid chromatography and post-column derivitization of gadolinium with arsenazo III. J Pharm Biomed Anal 13 (1995) 927-932
15. Ivanov V.M., and Ermakova N.V. Optical and chromaticity characteristics of arsenazo III complexes of rare-earth elements. J Anal Chem 56 (2001) 519-523
16. Kang H.P., Scott M.G., Joe B.N., Narra V., Heiken J., and Parvin C.A. Model for predicting the impact of gadolinium on plasma calcium measured by the o-cresolphthalein method. Clin Chem 50 (2004) 741-746
17. Kiessling F., Fink C., Hansen M., Bock M., Sinn H., Schrenk H.H., et al. Magnetic resonance imaging of nude mice with heterotransplanted high-grade cell carcinomas: use of a low-loaded, covalently bound Gd-Hsa conjugate as contrast agent with high tumor affinity. Invest Radiol 37 (2002) 193-198
18. Kim J.H., Khil M.S., Kolozsvary A., Gutierrez J.A., and Brown S.L. Fractionated radiosurgery for 9L gliosarcoma in the rat brain. Int J Radiat Oncol Biol Phys 45 (1999) 1035-1040
19. Knight R.A., Nagaraja T.N., Ewing J.R., Nagesh V., Whitton P.A., Bershad E., et al. Quantitation and localization of blood-to-brain influx by MRI and quantitative autoradiography in a model of transient focal ischemia. Magn Reson Med 54 (2005) 813-821
20. Koenig S.H., Brown III R.D., Adams D., Emerson D., and Harrison C.G. Magnetic field dependence of 1/T1 of protons in tissue. Invest Radiol 19 (1984) 76-81
21. Kornguth S.E., Turski P.A., Perman W.H., Schultz R., Kalinke T., Reale R., et al. Magnetic resonance imaging of gadolinium-labeled monoclonal antibody polymers directed at human T lymphocytes implanted in canine brain. J Neurosurg 66 (1987) 898-906
22. Look D.C., and Locker D.R. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 41 (1970) 250-251
23. Merten C.L., Knitelius H.O., Assheuer J., Bergmann-Kurz B., Hedde J.P., and Bewermeyer H. MRI of acute cerebral infarcts: increased contrast enhancement with continuous infusion of gadolinium. Neuroradiology 41 (1999) 242-248
24. Misselwitz B., Schmitt-Willich H., Ebert W., Frenzel T., and Weinmann H.J. Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrastagent. MAGMA 12 (2001) 128-134
25. 125I]albumin distribution in experimental RG-2 gliomas and adjacent brain. J Cereb Blood Flow Metab 7 6 (1987) 687-701
26. Niendorf H.P., Felix R., Laniado M., Schorner W., Claussen C., and Wienmann H.-J. Gadolinium-DTPA: a new contrast agent for magnetic resonance imaging. Radiat Med 3 (1985) 7-12
27. Ogan M.D., Schmiedl U., Moseley M.E., Grodd W., Paajanen H., and Brasch R.C. Albumin labeled with Gd-DTPA an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 22 (1987) 665-671
28. Pathak A.P., Artemov D., and Bhujwalla Z.M. Novel system for determining contrast agent concentration in mouse blood in vivo. Magn Reson Med 51 (2004) 612-615
29. Pathak A.P., Artemov D., Ward B.D., Jackson D.G., Neeman M., and Bhujwalla Z.M. Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging. Cancer Res 65 (2005) 1425-1432
30. Santoyo E., and Verma S.P. Determination of lanthanides in synthetic standards by reversed-phase high-performance liquid chromatography with the aid of a weighted least-squares regression model: estimation of method sensitivities and detection limits. J Chromatogr A 997 (2003) 171-182
31. Schmiedl U., Ogan M.D., Moseley M.E., and Brasch R.C. Comparison of the contrast enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: an experimental study in rats. Am J Radiol 147 (1986) 1263-1270
32. Spanoghe M., Lanens D., Dommisse R., Van Der Linden A., and Alderweireldt F. Proton relaxation enhancement by means of serum albumin and poly-l-lysine labeled with DTPA-Gd3+: relaxivities as a function of molecular weight and conjugation efficiency. Magn Resosn Imaging 10 (1992) 913-917
33. Su M.-Y. Characterization of n-ethyl-n-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents. J Magn Reson Imaging 9 (1999) 177-186
34. Su M.-Y., Najafi A., and Nalcioglu O. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med 34 (1995) 402-411
35. Su M.-Y., Wang Z., and Nalcioglu O. Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors. J Magn Reson Imaging 9 (1999) 128-137
36. Turetschek K., Preda A., Floyd E., Shames D.M., Novikov V., Roberts T.P., et al. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. Eur J Nucl Med Mol Imaging 30 3 (2003) 448-455
37. Turetschek K., Preda A., Novikov V., Brasch R.C., Weinmann H.J., Wunderbaldinger P., et al. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights. J Magn Resosn Imaging 20 (2004) 138-144
38. Weinmann H.-J., Brasch R.C., Press W.-R., and Wesbey G.E. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Radiol 142 (1984) 619-624